Swiss Industries in Turmoil: The U.S. Tariff Hike Impact

The U.S. has imposed a 39% tariff on Swiss exports, surpassing the previously expected rate. This levy threatens tens of thousands of Swiss jobs, especially impacting pharmaceuticals, watches, and machinery. While negotiations continue, the Swiss economy braces for weakened growth, as the U.S. demands trade concessions.


Devdiscourse News Desk | Updated: 02-08-2025 00:23 IST | Created: 02-08-2025 00:23 IST
Swiss Industries in Turmoil: The U.S. Tariff Hike Impact
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

Swiss manufacturers have been warned that tens of thousands of jobs are at risk following President Donald Trump's decision to impose a 39% tariff on Swiss exports. This move marks a drastic increase from the expected 31%, outpacing the general 15% rate applied to most European Union imports.

The Swiss government has expressed disappointment over the tariffs, which significantly impact the country's export-reliant economy, notably in sectors such as pharmaceuticals, watches, machinery, and chocolates. While Swiss officials remain open to dialogue, there is limited room for concessions due to existing free market access for U.S. imports.

Despite exemptions for the pharmaceuticals sector, uncertainties loom as a national security investigation could lead to additional tariffs. The threat reverberates through interconnected global supply chains, potentially impacting vital medication supplies, amidst ongoing negotiations between Switzerland and the U.S.

(With inputs from agencies.)

Give Feedback